NCT00478855View on ClinicalTrials.gov

Tazocin Intervention Study

PHASE4CompletedINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

June 30, 2007

Conditions

Bacterial Infections

Interventions

DRUG

Tazocin (Piperacillin/Tazobactem)

Trial Locations (1)

100730

Beijing

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00478855 - Tazocin Intervention Study | Biotech Hunter | Biotech Hunter